A functional promoter variant in IL12B predisposes to cerebral malaria

The role of the Th1 pathway in the pathogenesis of severe malaria is unclear. We recently reported that a polymorphism with increasing IFNG transcription is associated with protection against cerebral malaria (CM). Interleukin-12 is required for Th1 cell differentiation, which is characterized by th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human molecular genetics 2008-07, Vol.17 (14), p.2190-2195
Hauptverfasser: Marquet, Sandrine, Doumbo, Ogobara, Cabantous, Sandrine, Poudiougou, Belco, Argiro, Laurent, Safeukui, Innocent, Konate, Salimata, Sissoko, Sibiri, Chevereau, Estelle, Traore, Abdoulaye, Keita, Mamadou M., Chevillard, Christophe, Abel, Laurent, Dessein, Alain J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2195
container_issue 14
container_start_page 2190
container_title Human molecular genetics
container_volume 17
creator Marquet, Sandrine
Doumbo, Ogobara
Cabantous, Sandrine
Poudiougou, Belco
Argiro, Laurent
Safeukui, Innocent
Konate, Salimata
Sissoko, Sibiri
Chevereau, Estelle
Traore, Abdoulaye
Keita, Mamadou M.
Chevillard, Christophe
Abel, Laurent
Dessein, Alain J.
description The role of the Th1 pathway in the pathogenesis of severe malaria is unclear. We recently reported that a polymorphism with increasing IFNG transcription is associated with protection against cerebral malaria (CM). Interleukin-12 is required for Th1 cell differentiation, which is characterized by the production of interferon-γ. We investigated 21 markers in IL12-related genes, including IL12A and IL12B encoding the two IL-12 (IL12p70) subunits, IL12p35 and IL12p40. We performed a family-based association study using a total sample set of 240 nuclear families. The IL12Bpro polymorphism was associated with susceptibility to CM. The CTCTAA allele and the GC/CTCTAA genotype are over-transmitted to children with CM (P = 0.0002 and 0.00002, respectively). We estimated the odds ratio to be 2.11 for risk of CM in heterozygous children [(95% confidence interval, 1.49–2.99); P < 0.0001]. Although the CTCTAA allele had a dominant effect on CM susceptibility, this effect is much stronger in heterozygous children, consistent with the functional effects of this allele in a heterozygous form. Heterozygosity for this polymorphism has been associated with reduced expression of the gene encoding IL12p40 and a low level of IL12p70 production. These results, together with the findings from immunological studies of low interferon-γ and IL-12 levels in CM, support a protective role for the Th1 pathway in CM.
doi_str_mv 10.1093/hmg/ddn118
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_01592703v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/hmg/ddn118</oup_id><sourcerecordid>20921524</sourcerecordid><originalsourceid>FETCH-LOGICAL-c511t-84dbf622183091a22ec394efc0c18f828f4dfb59e51b8d1905ddc28aab09011e3</originalsourceid><addsrcrecordid>eNqF0c-L1DAUB_Agiju7evEPkCIoKNR9L0nT5Djuus7CiBcF8RLSJHW7ts2YtIv-92boMAse9BR4-byXH19CniG8RVDs_Gb4fu7ciCgfkBVyASUFyR6SFSjBS6FAnJDTlG4BUHBWPyYnKDkyRvmKXK2Ldh7t1IXR9MUuhiFMPhZ3JnZmnIpuLK63SN_lHe-6tAvJp2IKhfXRNzF3DKbf0yfkUWv65J8e1jPy5er954tNuf304fpivS1thTiVkrumFZSiZKDQUOotU9y3FizKVlLZctc2lfIVNtKhgso5S6UxDShA9OyMvF7m3phe72I3mPhbB9PpzXqr9zXAStEa2B1m-2qx-VU_Z58mPXTJ-r43ow9z0kJRoWoJ_4UUFMWK8gxf_AVvwxzzx2WDiEoxqTJ6syAbQ0rRt8d7Iuh9XjrnpZe8Mn5-mDg3g3f39BBQBi8PwCRr-jaa0Xbp6ChwyUGIexfm3b8PLBfXpcn_OkoTf2hRs7rSm6_fNHxEVV8yppH9AS4ptqk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>211199389</pqid></control><display><type>article</type><title>A functional promoter variant in IL12B predisposes to cerebral malaria</title><source>MEDLINE</source><source>Oxford University Press Journals Current</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Marquet, Sandrine ; Doumbo, Ogobara ; Cabantous, Sandrine ; Poudiougou, Belco ; Argiro, Laurent ; Safeukui, Innocent ; Konate, Salimata ; Sissoko, Sibiri ; Chevereau, Estelle ; Traore, Abdoulaye ; Keita, Mamadou M. ; Chevillard, Christophe ; Abel, Laurent ; Dessein, Alain J.</creator><creatorcontrib>Marquet, Sandrine ; Doumbo, Ogobara ; Cabantous, Sandrine ; Poudiougou, Belco ; Argiro, Laurent ; Safeukui, Innocent ; Konate, Salimata ; Sissoko, Sibiri ; Chevereau, Estelle ; Traore, Abdoulaye ; Keita, Mamadou M. ; Chevillard, Christophe ; Abel, Laurent ; Dessein, Alain J.</creatorcontrib><description>The role of the Th1 pathway in the pathogenesis of severe malaria is unclear. We recently reported that a polymorphism with increasing IFNG transcription is associated with protection against cerebral malaria (CM). Interleukin-12 is required for Th1 cell differentiation, which is characterized by the production of interferon-γ. We investigated 21 markers in IL12-related genes, including IL12A and IL12B encoding the two IL-12 (IL12p70) subunits, IL12p35 and IL12p40. We performed a family-based association study using a total sample set of 240 nuclear families. The IL12Bpro polymorphism was associated with susceptibility to CM. The CTCTAA allele and the GC/CTCTAA genotype are over-transmitted to children with CM (P = 0.0002 and 0.00002, respectively). We estimated the odds ratio to be 2.11 for risk of CM in heterozygous children [(95% confidence interval, 1.49–2.99); P &lt; 0.0001]. Although the CTCTAA allele had a dominant effect on CM susceptibility, this effect is much stronger in heterozygous children, consistent with the functional effects of this allele in a heterozygous form. Heterozygosity for this polymorphism has been associated with reduced expression of the gene encoding IL12p40 and a low level of IL12p70 production. These results, together with the findings from immunological studies of low interferon-γ and IL-12 levels in CM, support a protective role for the Th1 pathway in CM.</description><identifier>ISSN: 0964-6906</identifier><identifier>EISSN: 1460-2083</identifier><identifier>DOI: 10.1093/hmg/ddn118</identifier><identifier>PMID: 18413324</identifier><identifier>CODEN: HNGEE5</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Biological and medical sciences ; Child ; Cohort Studies ; Fundamental and applied biological sciences. Psychology ; Genetic Predisposition to Disease ; Genetics of eukaryotes. Biological and molecular evolution ; Heterozygote ; Human protozoal diseases ; Humans ; Infectious diseases ; Interleukin-12 Subunit p35 - genetics ; Interleukin-12 Subunit p40 - genetics ; Life Sciences ; Malaria ; Malaria, Cerebral - genetics ; Medical sciences ; Microbiology and Parasitology ; Molecular and cellular biology ; Odds Ratio ; Parasitic diseases ; Polymorphism, Genetic ; Promoter Regions, Genetic ; Protozoal diseases ; Receptors, Interleukin-12 - genetics ; STAT4 Transcription Factor - genetics</subject><ispartof>Human molecular genetics, 2008-07, Vol.17 (14), p.2190-2195</ispartof><rights>The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org 2008</rights><rights>2008 INIST-CNRS</rights><rights>The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c511t-84dbf622183091a22ec394efc0c18f828f4dfb59e51b8d1905ddc28aab09011e3</citedby><cites>FETCH-LOGICAL-c511t-84dbf622183091a22ec394efc0c18f828f4dfb59e51b8d1905ddc28aab09011e3</cites><orcidid>0000-0001-7011-6496 ; 0000-0001-7016-6493 ; 0000-0002-5269-8813</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,1578,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20484066$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18413324$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://amu.hal.science/hal-01592703$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Marquet, Sandrine</creatorcontrib><creatorcontrib>Doumbo, Ogobara</creatorcontrib><creatorcontrib>Cabantous, Sandrine</creatorcontrib><creatorcontrib>Poudiougou, Belco</creatorcontrib><creatorcontrib>Argiro, Laurent</creatorcontrib><creatorcontrib>Safeukui, Innocent</creatorcontrib><creatorcontrib>Konate, Salimata</creatorcontrib><creatorcontrib>Sissoko, Sibiri</creatorcontrib><creatorcontrib>Chevereau, Estelle</creatorcontrib><creatorcontrib>Traore, Abdoulaye</creatorcontrib><creatorcontrib>Keita, Mamadou M.</creatorcontrib><creatorcontrib>Chevillard, Christophe</creatorcontrib><creatorcontrib>Abel, Laurent</creatorcontrib><creatorcontrib>Dessein, Alain J.</creatorcontrib><title>A functional promoter variant in IL12B predisposes to cerebral malaria</title><title>Human molecular genetics</title><addtitle>Hum Mol Genet</addtitle><description>The role of the Th1 pathway in the pathogenesis of severe malaria is unclear. We recently reported that a polymorphism with increasing IFNG transcription is associated with protection against cerebral malaria (CM). Interleukin-12 is required for Th1 cell differentiation, which is characterized by the production of interferon-γ. We investigated 21 markers in IL12-related genes, including IL12A and IL12B encoding the two IL-12 (IL12p70) subunits, IL12p35 and IL12p40. We performed a family-based association study using a total sample set of 240 nuclear families. The IL12Bpro polymorphism was associated with susceptibility to CM. The CTCTAA allele and the GC/CTCTAA genotype are over-transmitted to children with CM (P = 0.0002 and 0.00002, respectively). We estimated the odds ratio to be 2.11 for risk of CM in heterozygous children [(95% confidence interval, 1.49–2.99); P &lt; 0.0001]. Although the CTCTAA allele had a dominant effect on CM susceptibility, this effect is much stronger in heterozygous children, consistent with the functional effects of this allele in a heterozygous form. Heterozygosity for this polymorphism has been associated with reduced expression of the gene encoding IL12p40 and a low level of IL12p70 production. These results, together with the findings from immunological studies of low interferon-γ and IL-12 levels in CM, support a protective role for the Th1 pathway in CM.</description><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Cohort Studies</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genetic Predisposition to Disease</subject><subject>Genetics of eukaryotes. Biological and molecular evolution</subject><subject>Heterozygote</subject><subject>Human protozoal diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Interleukin-12 Subunit p35 - genetics</subject><subject>Interleukin-12 Subunit p40 - genetics</subject><subject>Life Sciences</subject><subject>Malaria</subject><subject>Malaria, Cerebral - genetics</subject><subject>Medical sciences</subject><subject>Microbiology and Parasitology</subject><subject>Molecular and cellular biology</subject><subject>Odds Ratio</subject><subject>Parasitic diseases</subject><subject>Polymorphism, Genetic</subject><subject>Promoter Regions, Genetic</subject><subject>Protozoal diseases</subject><subject>Receptors, Interleukin-12 - genetics</subject><subject>STAT4 Transcription Factor - genetics</subject><issn>0964-6906</issn><issn>1460-2083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0c-L1DAUB_Agiju7evEPkCIoKNR9L0nT5Djuus7CiBcF8RLSJHW7ts2YtIv-92boMAse9BR4-byXH19CniG8RVDs_Gb4fu7ciCgfkBVyASUFyR6SFSjBS6FAnJDTlG4BUHBWPyYnKDkyRvmKXK2Ldh7t1IXR9MUuhiFMPhZ3JnZmnIpuLK63SN_lHe-6tAvJp2IKhfXRNzF3DKbf0yfkUWv65J8e1jPy5er954tNuf304fpivS1thTiVkrumFZSiZKDQUOotU9y3FizKVlLZctc2lfIVNtKhgso5S6UxDShA9OyMvF7m3phe72I3mPhbB9PpzXqr9zXAStEa2B1m-2qx-VU_Z58mPXTJ-r43ow9z0kJRoWoJ_4UUFMWK8gxf_AVvwxzzx2WDiEoxqTJ6syAbQ0rRt8d7Iuh9XjrnpZe8Mn5-mDg3g3f39BBQBi8PwCRr-jaa0Xbp6ChwyUGIexfm3b8PLBfXpcn_OkoTf2hRs7rSm6_fNHxEVV8yppH9AS4ptqk</recordid><startdate>20080715</startdate><enddate>20080715</enddate><creator>Marquet, Sandrine</creator><creator>Doumbo, Ogobara</creator><creator>Cabantous, Sandrine</creator><creator>Poudiougou, Belco</creator><creator>Argiro, Laurent</creator><creator>Safeukui, Innocent</creator><creator>Konate, Salimata</creator><creator>Sissoko, Sibiri</creator><creator>Chevereau, Estelle</creator><creator>Traore, Abdoulaye</creator><creator>Keita, Mamadou M.</creator><creator>Chevillard, Christophe</creator><creator>Abel, Laurent</creator><creator>Dessein, Alain J.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><general>Oxford University Press (OUP)</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>M7N</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0001-7011-6496</orcidid><orcidid>https://orcid.org/0000-0001-7016-6493</orcidid><orcidid>https://orcid.org/0000-0002-5269-8813</orcidid></search><sort><creationdate>20080715</creationdate><title>A functional promoter variant in IL12B predisposes to cerebral malaria</title><author>Marquet, Sandrine ; Doumbo, Ogobara ; Cabantous, Sandrine ; Poudiougou, Belco ; Argiro, Laurent ; Safeukui, Innocent ; Konate, Salimata ; Sissoko, Sibiri ; Chevereau, Estelle ; Traore, Abdoulaye ; Keita, Mamadou M. ; Chevillard, Christophe ; Abel, Laurent ; Dessein, Alain J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c511t-84dbf622183091a22ec394efc0c18f828f4dfb59e51b8d1905ddc28aab09011e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Cohort Studies</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genetic Predisposition to Disease</topic><topic>Genetics of eukaryotes. Biological and molecular evolution</topic><topic>Heterozygote</topic><topic>Human protozoal diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Interleukin-12 Subunit p35 - genetics</topic><topic>Interleukin-12 Subunit p40 - genetics</topic><topic>Life Sciences</topic><topic>Malaria</topic><topic>Malaria, Cerebral - genetics</topic><topic>Medical sciences</topic><topic>Microbiology and Parasitology</topic><topic>Molecular and cellular biology</topic><topic>Odds Ratio</topic><topic>Parasitic diseases</topic><topic>Polymorphism, Genetic</topic><topic>Promoter Regions, Genetic</topic><topic>Protozoal diseases</topic><topic>Receptors, Interleukin-12 - genetics</topic><topic>STAT4 Transcription Factor - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marquet, Sandrine</creatorcontrib><creatorcontrib>Doumbo, Ogobara</creatorcontrib><creatorcontrib>Cabantous, Sandrine</creatorcontrib><creatorcontrib>Poudiougou, Belco</creatorcontrib><creatorcontrib>Argiro, Laurent</creatorcontrib><creatorcontrib>Safeukui, Innocent</creatorcontrib><creatorcontrib>Konate, Salimata</creatorcontrib><creatorcontrib>Sissoko, Sibiri</creatorcontrib><creatorcontrib>Chevereau, Estelle</creatorcontrib><creatorcontrib>Traore, Abdoulaye</creatorcontrib><creatorcontrib>Keita, Mamadou M.</creatorcontrib><creatorcontrib>Chevillard, Christophe</creatorcontrib><creatorcontrib>Abel, Laurent</creatorcontrib><creatorcontrib>Dessein, Alain J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Human molecular genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marquet, Sandrine</au><au>Doumbo, Ogobara</au><au>Cabantous, Sandrine</au><au>Poudiougou, Belco</au><au>Argiro, Laurent</au><au>Safeukui, Innocent</au><au>Konate, Salimata</au><au>Sissoko, Sibiri</au><au>Chevereau, Estelle</au><au>Traore, Abdoulaye</au><au>Keita, Mamadou M.</au><au>Chevillard, Christophe</au><au>Abel, Laurent</au><au>Dessein, Alain J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A functional promoter variant in IL12B predisposes to cerebral malaria</atitle><jtitle>Human molecular genetics</jtitle><addtitle>Hum Mol Genet</addtitle><date>2008-07-15</date><risdate>2008</risdate><volume>17</volume><issue>14</issue><spage>2190</spage><epage>2195</epage><pages>2190-2195</pages><issn>0964-6906</issn><eissn>1460-2083</eissn><coden>HNGEE5</coden><abstract>The role of the Th1 pathway in the pathogenesis of severe malaria is unclear. We recently reported that a polymorphism with increasing IFNG transcription is associated with protection against cerebral malaria (CM). Interleukin-12 is required for Th1 cell differentiation, which is characterized by the production of interferon-γ. We investigated 21 markers in IL12-related genes, including IL12A and IL12B encoding the two IL-12 (IL12p70) subunits, IL12p35 and IL12p40. We performed a family-based association study using a total sample set of 240 nuclear families. The IL12Bpro polymorphism was associated with susceptibility to CM. The CTCTAA allele and the GC/CTCTAA genotype are over-transmitted to children with CM (P = 0.0002 and 0.00002, respectively). We estimated the odds ratio to be 2.11 for risk of CM in heterozygous children [(95% confidence interval, 1.49–2.99); P &lt; 0.0001]. Although the CTCTAA allele had a dominant effect on CM susceptibility, this effect is much stronger in heterozygous children, consistent with the functional effects of this allele in a heterozygous form. Heterozygosity for this polymorphism has been associated with reduced expression of the gene encoding IL12p40 and a low level of IL12p70 production. These results, together with the findings from immunological studies of low interferon-γ and IL-12 levels in CM, support a protective role for the Th1 pathway in CM.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>18413324</pmid><doi>10.1093/hmg/ddn118</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-7011-6496</orcidid><orcidid>https://orcid.org/0000-0001-7016-6493</orcidid><orcidid>https://orcid.org/0000-0002-5269-8813</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0964-6906
ispartof Human molecular genetics, 2008-07, Vol.17 (14), p.2190-2195
issn 0964-6906
1460-2083
language eng
recordid cdi_hal_primary_oai_HAL_hal_01592703v1
source MEDLINE; Oxford University Press Journals Current; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Biological and medical sciences
Child
Cohort Studies
Fundamental and applied biological sciences. Psychology
Genetic Predisposition to Disease
Genetics of eukaryotes. Biological and molecular evolution
Heterozygote
Human protozoal diseases
Humans
Infectious diseases
Interleukin-12 Subunit p35 - genetics
Interleukin-12 Subunit p40 - genetics
Life Sciences
Malaria
Malaria, Cerebral - genetics
Medical sciences
Microbiology and Parasitology
Molecular and cellular biology
Odds Ratio
Parasitic diseases
Polymorphism, Genetic
Promoter Regions, Genetic
Protozoal diseases
Receptors, Interleukin-12 - genetics
STAT4 Transcription Factor - genetics
title A functional promoter variant in IL12B predisposes to cerebral malaria
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T23%3A50%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20functional%20promoter%20variant%20in%20IL12B%20predisposes%20to%20cerebral%20malaria&rft.jtitle=Human%20molecular%20genetics&rft.au=Marquet,%20Sandrine&rft.date=2008-07-15&rft.volume=17&rft.issue=14&rft.spage=2190&rft.epage=2195&rft.pages=2190-2195&rft.issn=0964-6906&rft.eissn=1460-2083&rft.coden=HNGEE5&rft_id=info:doi/10.1093/hmg/ddn118&rft_dat=%3Cproquest_hal_p%3E20921524%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=211199389&rft_id=info:pmid/18413324&rft_oup_id=10.1093/hmg/ddn118&rfr_iscdi=true